A citation-based method for searching scientific literature

B Meiser, P Butow, M Friedlander, A Barratt, V Schnieden, M Watson, J Brown, K Tucker. Eur J Cancer 2002
Times Cited: 93







List of co-cited articles
668 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
41

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
37

Psychological impact of receiving a BRCA1/BRCA2 test result.
L Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, A M van den Ouweland,[...]. Am J Med Genet 2001
116
33

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
33

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
244
33

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
118
27

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
23

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
195
23

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
21





One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan G M Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine M A Tilanus, Carina C M Bartels, Leon C Verhoog,[...]. Breast Cancer Res Treat 2002
129
17


Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
242
16


The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
M Watson, S Lloyd, J Davidson, L Meyer, R Eeles, S Ebbs, V Murday. Br J Cancer 1999
186
15

Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
B Meiser, V Collins, R Warren, C Gaff, D J B St John, M-A Young, K Harrop, J Brown, J Halliday. Clin Genet 2004
62
22

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
M Dorval, A F Patenaude, K A Schneider, S A Kieffer, L DiGianni, K J Kalkbrenner, J I Bromberg, L A Basili, K Calzone, J Stopfer,[...]. J Clin Oncol 2000
100
13

Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
Brita Arver, Aina Haegermark, Ulla Platten, Annika Lindblom, Yvonne Brandberg. Fam Cancer 2004
46
28

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
12

Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review.
Phyllis N Butow, Elizabeth A Lobb, Bettina Meiser, Alexandra Barratt, Katherine M Tucker. Med J Aust 2003
123
12

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
12



Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
11

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.
Jeffrey R Botkin, Ken R Smith, Robert T Croyle, Bonnie J Baty, Jean E Wylie, Debra Dutson, Anna Chan, Heidi A Hamann, Caryn Lerman, Jamie McDonald,[...]. Am J Med Genet A 2003
156
11

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
176
11

Genetic testing: psychological aspects and implications.
Caryn Lerman, Robert T Croyle, Kenneth P Tercyak, Heidi Hamann. J Consult Clin Psychol 2002
179
11

What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?
James C Coyne, Linda Kruus, Melissa Racioppo, Kathleen A Calzone, Katrina Armstrong. Am J Med Genet A 2003
43
25


Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.
Erna Claes, Lieve Denayer, Gerry Evers-Kiebooms, Andrea Boogaerts, Eric Legius. Patient Educ Couns 2004
63
17

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
Mariëlle S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Am J Med Genet A 2004
49
22

Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure.
E Claes, G Evers-Kiebooms, L Denayer, M Decruyenaere, A Boogaerts, K Philippe, E Legius. J Genet Couns 2005
49
22

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
63
17

A literature review of the psychological impact of genetic testing on breast cancer patients.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Margreet G E M Ausems. Patient Educ Couns 2006
63
17


Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Genet Test 2004
36
27

Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Ashley Wilder Smith, Angela Liegey Dougall, Donna M Posluszny, Tamara J Somers, Wendy S Rubinstein, Andrew Baum. Psychooncology 2008
52
19

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
L N Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, P Devilee,[...]. J Med Genet 1999
60
15

Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
179
9

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
9

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
487
9

No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches.
Alison Bish, Stephen Sutton, Christine Jacobs, Sara Levene, Amanda Ramirez, Shirley Hodgson. Genet Med 2002
31
29

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Valérie Bonadona, Pierre Saltel, Françoise Desseigne, Hervé Mignotte, Jean-Christophe Saurin, Qing Wang, Olga Sinilnikova, Sophie Giraud, Gilles Freyer, Henri Plauchu,[...]. Cancer Epidemiol Biomarkers Prev 2002
66
13


The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress.
A Cull, E D Anderson, S Campbell, J Mackay, E Smyth, M Steel. Br J Cancer 1999
123
9


Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.
Amy Østertun Geirdal, Jon G Reichelt, Alv A Dahl, Ketil Heimdal, Lovise Maehle, Astrid Stormorken, Pål Møller. Fam Cancer 2005
30
30


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.